Investors in exchange-traded funds will soon be able to hedge the world’s safest asset.
Innovator ETFs will launch two so-called buffer funds tracking long-dated Treasuries next Tuesday, according to a company statement Friday. They’ll be the first fixed-income products of that category to begin trading amid a surge in popularity for defined-outcome equity funds, which shield holders against a certain percentage of declines in exchange for a cap on gains.
Buffer funds are increasingly luring investors as stocks reach new highs and coronavirus cases continue to rise. The new ETFs will also debut at a time when Treasury yields are hovering near historic lows, while duration risk -- a measure of sensitivity to interest-rate changes -- is climbing.
Rock-bottom rates have raised questions about the viability of Treasuries as a hedge in traditional portfolio mixes such as 60% equities and 40% fixed-income.
Bond buffer ETFs would give advisers a tool to protect their portfolios against the risk of yields turning sharply higher, said to Bruce Bond, CEO at Innovator.
“Historically, it hasn’t been as important as it is today when rates are so low and duration is so extreme,” Bond said. “You’re still going to get a portion of the upside, but the great thing is we’re going to be able to hedge your downside.”
The Innovator 20+ Year Treasury Bond 5 Floor ETF - JULY (TFJL) and the Innovator 20+ Year Treasury Bond 9 Buffer ETF - JULY (TBJL) will provide buffered exposure to the performance of BlackRock Inc.’s iShares 20+ Year Treasury Bond ETF (TLT). Both Innovator funds will have a 0.79% fee.
Investors have plowed over $2.3 billion into defined-outcome ETFs so far this year, according to data compiled by Bloomberg. While Innovator commands the lion’s share of assets, competition is building. Allianz Investment Management launched two buffer ETFs in June, and New York Life Investments’ IndexIQ unit has also filed plans.

Still, a bond buffer ETF might not drum up the strong demand seen for their equity counterparts.
“Equity ETFs are an easier sell and more intuitive to the average person,” said Bloomberg Intelligence analyst James Seyffart. “While the TLT buffer products could definitely be a useful tool in certain situations and for certain investors and strategies, I think the equity products have broader appeal.”
Wells Fargo adds two bank-channel recruits, UBS lands a JPMorgan Chase veteran, and a multi-family office lifts Atlas past $1B
“The state comes down on you in years when you make 40% returns for clients,” said Bill Swayne, the advisor and son of Candace Swayne.
The Independent broker-dealer giant has had “active conversations” with the Claude maker, which is days away from its expected IPO
For Gen X clients entering life after work, answering the financial question isn't enough to solve the entire retirement equation.
Tools from Grantd, Income Lab and Healthspan Wealth aim to keep RIAs involved in clients’ biggest money decisions
Growing wealth, evolving priorities, and untapped opportunities are reshaping how women approach long-term investing.
Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.